{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:54:10Z","timestamp":1777456450119,"version":"3.51.4"},"reference-count":37,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Breastfeeding Medicine"],"published-print":{"date-parts":[[2024,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>The study aimed to assess the transfer of merotocin from systemic circulation to breast milk in early postpartum women and women with established lactation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      This was a two-part, multicenter, open-label, parallel-group study. Merotocin was administered as a single 90-minute intravenous (iv) infusion mimicking the intranasal pharmacokinetic profile. In Part A, 12 early postpartum women received doses of either 4 \u03bcg (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 6) or 16 \u03bcg (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 6) of merotocin within 4 days of delivery. In Part B, six women with established lactation received 20 \u03bcg of merotocin. The total concentration of merotocin in plasma and breast milk and its metabolites excreted in breast milk were measured at various time points. Adverse events (AEs) were also assessed for both parts of the study.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In both early postpartum and established lactation groups (mean age, 26.3 years; 83.3% Caucasian), merotocin and its metabolites in breast milk were below the limit of quantification (25.0 pg\/mL) at all time points. Sixteen treatment-emergent AEs occurred in early postpartum women only, including seven events of uterine spasm and three of breast engorgement. There was one moderate event, whereas all the other events were considered mild.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Merotocin was undetectable in breast milk after single iv administration of up to 20 \u03bcg in early postpartum women and women with established lactation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/bfm.2024.0044","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T07:56:05Z","timestamp":1711439765000},"page":"451-458","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["No Measurable Transfer of Oxytocin-Receptor Agonist Merotocin Detected in Human Breast Milk"],"prefix":"10.1177","volume":"19","author":[{"given":"Teresa","family":"Baker","sequence":"first","affiliation":[{"name":"Texas Tech University Health Sciences Center School of Medicine, Amarillo, Texas, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Lorch","sequence":"additional","affiliation":[{"name":"Richmond Pharmacology Limited, London, UK."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Bagger","sequence":"additional","affiliation":[{"name":"Ferring Pharmaceuticals, A\/S, Copenhagen, Denmark."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carina","family":"Holmqvist","sequence":"additional","affiliation":[{"name":"Ferring Pharmaceuticals, A\/S, Copenhagen, Denmark."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dani\u00ebl M.","family":"Jonker","sequence":"additional","affiliation":[{"name":"Ferring Pharmaceuticals, A\/S, Copenhagen, Denmark."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorien E.","family":"Urban","sequence":"additional","affiliation":[{"name":"Ferring Pharmaceuticals, Inc., Parsippany, New Jersey, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9349-8722","authenticated-orcid":false,"given":"Thomas W.","family":"Hale","sequence":"additional","affiliation":[{"name":"Texas Tech University Health Sciences Center School of Medicine, Amarillo, Texas, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01024-7"},{"key":"e_1_3_5_3_2","unstructured":"World Health Organization. Infant and young child feeding. 2021. Available from: www.who.int\/news-room\/fact-sheets\/detail\/infant-and-young-child-feeding [Last accessed: January12 2024]."},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/apa.15534"},{"key":"e_1_3_5_5_2","unstructured":"World Health Organization. 2022. WHO recommendations for the care of the preterm or low-birth-weight infant. Available from: www.ncbi.nlm.nih.gov\/books\/NBK586704\/ [Last accessed: January12 2024]."},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.4081\/pmc.2017.155"},{"issue":"1","key":"e_1_3_5_7_2","first-page":"1","article-title":"Births: Final data for 2021","volume":"72","author":"Osterman MJK","year":"2023","unstructured":"Osterman MJK, , Hamilton BE, , Martin JA, et al. Births: Final data for 2021. Natl Vital Stat Rep, 2023; 72(1):1\u201353.","journal-title":"Natl Vital Stat Rep"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-018-1693-5"},{"key":"e_1_3_5_9_2","unstructured":"Abrams SA Hurst NM. Breast milk expression for the preterm infant. 2022. Available from: www.uptodate.com\/contents\/breast-milk-expression-for-the-preterm-infant [Last accessed: January12 2024]."},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-054272"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu11050974"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1089\/bfm.2019.0247"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004253"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-6-17"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu10050600"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2004.08.002"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.283.6287.340"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2005.081265"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007010029"},{"key":"e_1_3_5_20_2","volume-title":"StatPearls [Internet]","author":"Osilla EV","year":"2023","unstructured":"Osilla EV, , Sharma S. Oxytocin. StatPearls [Internet]. StatPearls Publishing: Treasure Island, FL; 2023."},{"issue":"3","key":"e_1_3_5_21_2","first-page":"CD005544","article-title":"Medications for increasing milk supply in mothers expressing breastmilk for their preterm hospitalised infants","volume":"14","author":"Donovan TJ","year":"2012","unstructured":"Donovan TJ, , Buchanan K. Medications for increasing milk supply in mothers expressing breastmilk for their preterm hospitalised infants. Cochrane Database Syst Rev, 2012; 14(3):CD005544; doi: 10.1002\/14651858.CD005544.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/0890334416680176"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000151113.33698.a8"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-200282"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-015-0360-0"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.14802\/jmd.21151"},{"key":"e_1_3_5_27_2","unstructured":"US Food and Drug Administration. FDA talk paper: FDA warns against women using unapproved drug domperidone to increase milk production. 2004. Available from: www.fda.gov\/drugs\/information-drug-class\/fda-talk-paper-fda-warns-against-women-using-unapproved-drug-domperidone-increase-milk-production [Last accessed: January12 2024]."},{"key":"e_1_3_5_28_2","unstructured":"European Medicines Agency. CMDh confirms recommendations on restricting use of domperidone-containing medicines. 2014. Available from: www.ema.europa.eu\/en\/news\/cmdh-confirms-recommendations-restricting-use-domperidone-containing-medicines [Last accessed: January12 2024]."},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm500365s"},{"key":"e_1_3_5_30_2","unstructured":"Ferring Pharmaceuticals data on file."},{"issue":"1","key":"e_1_3_5_31_2","first-page":"1","article-title":"Pharmacokinetics and bioavailability of a novel highly specific oxytocin receptor agonist","volume":"4","author":"Olsson H","year":"2015","unstructured":"Olsson H, , Sandstrom R, , Kristoffersson V, et al. Pharmacokinetics and bioavailability of a novel highly specific oxytocin receptor agonist. Clin Pharmacol Drug Dev, 2015; 4(1_suppl):1\u201360; doi: 10.1002\/cpdd.216","journal-title":"Clin Pharmacol Drug Dev"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.4172\/2161-0509.1000112"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1089\/bfm.2016.0052"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2017.04.030"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14845-5"},{"issue":"8","key":"e_1_3_5_36_2","doi-asserted-by":"crossref","first-page":"e0235806","DOI":"10.1371\/journal.pone.0235806","article-title":"Maternal plasma levels of oxytocin during breastfeeding: A systematic review","volume":"15","author":"Uvnas Moberg K","year":"2020","unstructured":"Uvnas Moberg K, , Ekstrom-Bergstrom A, , Buckley S, et al. Maternal plasma levels of oxytocin during breastfeeding: A systematic review. PLoS One, 2020; 15(8):e0235806; doi: 10.1371\/journal.pone.0235806","journal-title":"PLoS One"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.742236"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2015.152"}],"container-title":["Breastfeeding Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/bfm.2024.0044","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/bfm.2024.0044","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/bfm.2024.0044","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:01:56Z","timestamp":1777381316000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/bfm.2024.0044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,1]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,1]]}},"alternative-id":["10.1089\/bfm.2024.0044"],"URL":"https:\/\/doi.org\/10.1089\/bfm.2024.0044","relation":{},"ISSN":["1556-8253","1556-8342"],"issn-type":[{"value":"1556-8253","type":"print"},{"value":"1556-8342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,1]]}}}